FDA Investigator Richmond K Yip

Richmond K Yip has conducted inspections on 86 sites in 5 countries as of 11 Mar 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
86
Last Inspection Date:
11 Mar 2024
Investigator Role:
FDA Investigator
Redica ID:
100006000
Countries of Inspections:
United States of America, India, Japan, France, Italy
FDA Investigators that have inspected at least one site in common with Richmond K Yip:
Aditi S Thakur, Alan L Truong, Alan P Kurtzberg, Alejandra Mcclellan, Alexander M Kay, Alexandra B Pitkin, Alexandria L Capuano, Amalia C Himaya, Amanda L Fyles, Amir Alavi, Ana Djurdjevic, Anastasia M Shields, Angela Shepas, Angelina M Albert, Anita Narula, PhD, April P Shaw, Arie C Menachem, Armando Chavez, MS, Arsen Karapetyan, Ashar P Parikh, Babajide Michael Osunsanmi, Barbara J Rincon, Barry Cherney, PhD, Bichsa T Tran, Binh T Nguyen, Bo Chi, PhD, Bonnie I Needleman, Brian D Nicholson, Brian E Thompson, Brian J Ryan, Brian P Putz, Brien C Fox, Bryan A Galvez, Bryan L Mcguckin, Bush, Carla J Lundi, Carrie A Hughes, Caryn M Everly, Caryn M Mcnab, Cassandra L Abellard, Cathleen A Carr Sharpe, Cecilia H Kieu, Celena Ngo, Charles D Brown, Charles L Larson, Chelsea N Sealey, Cheron M Portee, Chorng M Cheng, Christina C Santos, Christina D Mello, Christina V Santos, Christopher D Washington, Christopher J Freebairn, Christopher M Jenner, Christopher R Czajka, Claudia Mperez Kasmarski, Cynthia Jim, CSO, Daniel W Cline, Darren S Brown, Darrin E Davis, David G Whitman, David H Hsu, David Y Hernandez, Davinna Ligons, PhD, Davis, Deborah A Greco, Deborah G Park, Deborah W Hsu, Debra J Fracassa, Desiree C Iya, Devon Jenkins, Deyaa Shaheen, Diana M Rand, Diane Cvan Leeuwen, Doan T Nguyen, PharmD, Dogbeda F Mackenzie, Donna Ltartaglino Besone, Donna Mwilliams Hill, PhD, Dr. Chunchang Fang, Dyana K Stone, Eileen T Dupont, Elaine A Bunch, Esther B Gamallo Herrera, Esther C Broner, PhD, Evelyn Wong, Finn A Slizza, Frances Namuswe, PhD, Francisco, Gabriel Craig, Garciam, Gene D Arcy, George J Flynn, Gordon Chu, Greg K Keshishyan, Guerlain Ulysse, Hagstrom, Haley H Seymour, Haroon Vohra (NMI), Hasan A Irier, PhD, Helen B Ricalde, Helen Verdel, Herminio C Francisco, Hung H Do, MS, Iris C Macinnes, Ivar J Sohn, Jai P Singh, James P Stallings, James R Fleckenstein, Jane S Wernberg, Janete F Guardia, Jasmine N Thompson, Javier O Vega, Jee Chung, PhD, Jeff M Uriarte, Jeffery A Johnson, Jeffrey P Raimondi, Jennifer Gogley, Jennifer M Gogley, Jessica L Pressley, Jinnie Kokiatkulkij, Joanne E King, Joel D Hustedt, Joel Welch, PhD, Joey V Quitania, John A Gonzalez, John R Myung, Jolanna A Norton, Jose A Lopez, Jose Acruz Gonzalez, Jose R Hernandez, Joshua P Wireman, Juan J Casado, Juanita Banuelos, Judy C Nepsa, Julia Ventura, Junho Pak, Ka L Wong, Kai Wang, Kari M Johansen, Katherine E Jacobitz, Katherine Szestypalow, Kathleen R Jones, PhD, Kelley, Kelvin Cheung, Kelvin X Sanders, Kendra A Biddick, Kevin D Kallander, Kham Phommachanh, Khoa Nathanv Tran, Kim Lthomas Cruse, Kirsten S Tharp, Kirtida Patel, Kristy A Zielny, Lance A Finnical, Lata C Mathew, PhD, Laura Fontan, MS, Leonard H Lavi, Lilly O Barton, Liming Zhang, Linda F Murphy, Linda Thai, Lindsey M Schwierjohann, Loretta J Jordan, LT Tamara J Henderson, Lucila B Nwatu, Luis A Dasta, Luis Mburgos Medero, Luis P Torres, M A Abel I, M Jasnethoson Thompson, Mai X Huynh, Marcellinus D Dordunoo, Marcia B Williams, Marcus F Yambot, Marianela Aponte Cruz, Marie F Morin, Mark C Saale, Mary Ewilkerson Brinsko, Matt D Suedkamp, Matthew B Casale, Matthew R Clabeaux, Maurice M Sheehan, Maxyne T Lam, Michael D Garcia, Michael R Goga, Michael S Araneta, Michele L Obert, Michelle A Marsh, Michelle J Hines, Mihaly S Ligmond, Mohsen Rajabi Abhari, FDA, Muralidhara B Gavini, PhD, Nabeela J Chaudhry, Natalie J Ayoub, Nelly N Tran, Nianna C Burns, Nicholas L Hunt, Nicholas Obiri, PhD, Nicola M Fenty Stewart, Omotunde O Osunsanmi, Parul M Patel, Patty P Kaewussdangkul, Peter E Baker, Peter S Diak, Phillip J Sample, Phillip L Toy, Rabin N Ghoshal, Rafael A Kaup, Randall N Johnson, Randy L Self, Raymond W Brullo, Rebecca E Dombrowski, Rebecca Rodriguez, Regina T Brown, Richard A Abate, Richard W Tubb, Robert C Hoover, Robert D Tollefsen, Robert Darius, Robert T Lorenz, Rocio Guzman Velazquez, Roger F Zabinski, Rona Leblanc, PhD, Ronald L Koller, Ronda Leblanc, Rory K Geyer, Rumany C Penn, PharmD, S Lori Brown, PhD MPH, Saied A Asbagh, Sandra A Boyd, Sandra A Hughes, Sandra L Shire, DMD, MPA, Santiago Gallardo Johnson, Sarah A Hassas, Sarah Arden, Scott R Nichols, PhD, Sean P Desbrow, Selene T Torres, Sherri N Rohlf, MD, Shirley H Isbill, Sidney B Priesmeyer, Sidonie J Takougang, Simone E Pitts, Sonia R Peterson, Sonya L Karsik, RAC, Stacie A Woods, Stanley Au, Stephanie A Slater, MS, Steven Fong, MS, PhD, Sue Lee Chan, Sumit Sen, Sundy V Sedwick, Susan K Bain, Susan P Bruederle, Susan W Ting, Susanna N Choi, Taichun Qin, PhD, Tamala P Bogan, Tamala P Magee, Tamara L Ely, Tamika White, Tanya E Malais, Tara L Stockton, Tawny L Colling, Ted L Anderson, Terri L Dodds, Thanh M Andrews, Thao T Kwan, Thao X Tran, Thomas J Arista, Thomas R Beilke, Timothy T Kapsala, Tony J Wu, Tracey T Duong, Truong Xuan Nguyen (Andy), Uttaniti Limchumroon (Tom), Vasant G Malshet, PhD, Vashti E Bocker, Victor H Loo, Vioela J Caze, Virgilio F Pacio, CSO, Walden H Lee, Wenzheng Wendy Zhang, Yi Lin, Yumi J Hiramine, Yvette E Guillermo, Yvette Mlacour Davis, Yvonne C Wilkes, Yvonne T Lacour, Zachary A Bogorad, Zachary L Miller

Richmond K Yip's Documents

Publish Date Document Type Title
July, 2002 FDA 483 Amgen, Inc - Form 483, 2002-07-25
November, 2018 EIR INDUSTRIA FARMACEUTICA GALENICA SENESE SRL - EIR, 2018-11-16
May, 2001 FDA 483 Response Sokol, William N., M.D. - Form 483R, 2001-05-18
July, 2019 EIR Glenmark Life Sciences Limited - EIR, 2019-07-05
November, 2001 EIR B. Braun Medical Inc. - EIR, 2001-12-18
August, 2003 EIR Shimadzu Techno Research Inc. - EIR, 2003-10-08
September, 2003 FDA 483 Sumika Fine Chemicals Co. - Form 483, 2003-09-04
May, 2013 EIR Johnson & Johnson Consumer Inc. - EIR, 2013-05-16
March, 2001 FDA 483 Response Truett Laboratories, Inc. - Form 483R, 2001-06-04
March, 2001 FDA 483 Truett Laboratories, Inc. - Form 483, 2001-03-16
February, 2003 EIR Watson Pharmaceuticals Inc - EIR, 2003-02-24
November, 2018 FDA 483 Response INDUSTRIA FARMACEUTICA GALENICA SENESE SRL - Form 483R, 2018-12-07
September, 2003 FDA 483 Response Sumitomo Chemical Company, Limited - Form 483R, 2003-09-30
October, 2018 FDA 483 DISHMAN CARBOGEN AMCIS LIMITED - Form 483, 2018-10-26
August, 2003 FDA 483 Response Astellas Pharma Inc. - Form 483R, 2003-09-18
January, 2000 EIR Joseph S. Gimbel, MD - EIR, 2000-01-28
December, 2002 FDA 483 PureTek Corporation - Form 483, 2002-12-12
May, 2000 EIR Ishaque, Saleem MD - EIR, 2000-05-10
July, 2002 EIR Amgen, Inc - EIR, 2002-07-25
June, 2002 FDA 483 Merck Lipha S.A.S. Centre de Production de Meyzieu - Form 483, 2002-06-11
August, 2003 FDA 483 Nisshin Pharma Inc. - Form 483, 2003-08-29
July, 2000 FDA 483 Response NBTY Acquisition LLC - Form 483R, 2000-07-31
March, 2001 EIR Truett Laboratories, Inc. - EIR, 2001-03-16
September, 2001 EIR Gary J. Schiller, MD - EIR, 2001-09-21
October, 2001 EIR Chu, Franklin M., M.D. - EIR, 2001-10-11
March, 2002 FDA 483 Med-Pharmex, Inc - Form 483, 2002-03-20
July, 2000 FDA 483 Gill, Parkash S., M.D. - Form 483, 2000-07-13
September, 2001 FDA 483 Gary J. Schiller, MD - Form 483, 2001-09-21
August, 2003 FDA 483 Response Shimadzu Techno Research Inc. - Form 483R, 2003-10-21
October, 2018 EIR DISHMAN CARBOGEN AMCIS LIMITED - EIR, 2018-10-26
August, 2003 EIR Astellas Pharma Inc. - EIR, 2003-10-08
November, 2001 FDA 483 B. Braun Medical Inc. - Form 483, 2001-11-20
July, 2019 EIR Johnson & Johnson Private Limited - EIR, 2019-07-10
December, 2000 EIR Stephen G. Thein, Ph.D. - EIR, 2000-12-22
July, 2019 FDA 483 Glenmark Life Sciences Limited - Form 483, 2019-07-05
July, 2010 FDA 483 Person and Covey - Form 483, 2010-07-23
October, 2001 FDA 483 Chu, Franklin M., M.D. - Form 483, 2001-10-11
December, 2000 FDA 483 Stephen G. Thein, Ph.D. - Form 483, 2000-12-22
July, 2000 EIR Gill, Parkash S. Md - EIR, 2000-07-13
June, 2002 FDA 483 Merck Sante SAS - Form 483, 2002-06-18
August, 2000 EIR NBTY Acquisition LLC - EIR, 2000-08-09
July, 2000 FDA 483 Leiner Health Products, Inc. - Form 483, 2000-07-13
July, 2010 FDA 483 Response PureTek Corporation - Form 483R, 2010-07-28
July, 2002 FDA 483 Response Amgen, Inc - Form 483R, 2002-08-09
November, 2002 FDA 483 Truett Laboratories, Inc. - Form 483, 2002-11-06
November, 2018 FDA 483 INDUSTRIA FARMACEUTICA GALENICA SENESE SRL - Form 483, 2018-11-16
May, 2001 EIR Sokol, William N., M.D. - EIR, 2001-05-09
September, 2003 EIR Sumitomo Chemical Company, Limited - EIR, 2003-10-09
July, 2000 EIR NBTY Acquisition LLC - EIR, 2000-07-13
August, 2003 FDA 483 Astellas Pharma Inc. - Form 483, 2003-08-22
March, 2020 EIR Johnson & Johnson Consumer Inc. - EIR, 2020-03-11
February, 2002 FDA 483 North American Science Associates, LLC - Form 483, 2002-02-01
July, 2010 FDA 483 PureTek Corporation - Form 483, 2010-07-16
October, 2002 FDA 483 Maruchan, Inc. - Form 483, 2002-10-03
September, 2021 FDA 483 Vitae Enim Vitae Scientific, Inc. - Form 483, 2021-09-22

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more